Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 1405950, 10 pages
http://dx.doi.org/10.1155/2016/1405950
Research Article

Selective Subnormal IgG1 in 54 Adult Index Patients with Frequent or Severe Bacterial Respiratory Tract Infections

1Department of Medicine, Brookwood Medical Center, Birmingham, AL 35209, USA
2Southern Iron Disorders Center, Birmingham, AL 35209, USA
3Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35209, USA
4Brookwood Biomedical, Birmingham, AL 35209, USA
5Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA

Received 3 December 2015; Revised 15 January 2016; Accepted 27 January 2016

Academic Editor: Teresa Espanol

Copyright © 2016 James C. Barton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Herrod, “Clinical significance of IgG subclasses,” Current Opinion in Pediatrics, vol. 5, no. 6, pp. 696–699, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Buckley, “Immunoglobulin G subclass deficiency: fact or fancy?” Current Allergy and Asthma Reports, vol. 2, no. 5, pp. 356–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Aghamohammadi, V. Lougaris, A. Plebani, T. Miyawaki, A. Durandy, and L. Hammarström, “Predominantly antibody deficiencies,” in Primary Immunodeficiency Diseases, N. Rezaei, A. Aghamohammadi, and L. D. Notarangelo, Eds., chapter 3, pp. 97–130, Springer, Berlin, Germany, 2008. View at Publisher · View at Google Scholar
  4. R. Jefferis and D. S. Kumararatne, “Selective IgG subclass deficiency: quantification and clinical relevance,” Clinical and Experimental Immunology, vol. 81, no. 3, pp. 357–367, 1990. View at Google Scholar · View at Scopus
  5. P. Aucouturier, C. Lacombe, and J. L. Preud'homme, “Serum IgG subclass level determination: methodological difficulties and practical aspects,” Annales de Biologie Clinique, vol. 52, no. 1, pp. 53–56, 1994. View at Google Scholar · View at Scopus
  6. C. Lacombe, P. Aucouturier, and J.-L. Preud'homme, “Selective IgG1 deficiency,” Clinical Immunology and Immunopathology, vol. 84, no. 2, pp. 194–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Van Kessel, P. E. Horikx, A. J. Van Houte, C. S. De Graaff, H. Van Velzen-Blads, and G. T. Rijkers, “Clinical and immunological evaluation of patients with mild IgG1 deficiency,” Clinical and Experimental Immunology, vol. 118, no. 1, pp. 102–107, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Schauer, F. Stemberg, C. H. Rieger et al., “IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with The Binding Site reagents,” Clinical Chemistry, vol. 49, no. 11, pp. 1924–1929, 2003. View at Publisher · View at Google Scholar
  9. G. Vidarsson, G. Dekkers, and T. Rispens, “IgG subclasses and allotypes: from structure to effector functions,” Frontiers in Immunology, vol. 5, article 520, pp. 1–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Conley, L. D. Notarangelo, and A. Etzioni, “Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies),” Clinical Immunology, vol. 93, no. 3, pp. 190–197, 1999. View at Publisher · View at Google Scholar
  11. J. C. Barton, L. F. Bertoli, and R. T. Acton, “HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama,” BMC Medical Genetics, vol. 4, article 3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Oliveira and T. A. Fleisher, “Laboratory evaluation of primary immunodeficiencies,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, supplement 2, pp. S297–S305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. O'Keeffe, A. Gzel, R. Drury, M. Cullina, J. Greally, and P. Finnegan, “Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 4, no. 8, pp. 932–936, 1991. View at Google Scholar · View at Scopus
  14. S. L. Hill, J. L. Mitchell, D. Burnett, and R. A. Stockley, “IgG subclasses in the serum and sputum from patients with bronchiectasis,” Thorax, vol. 53, no. 6, pp. 463–468, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Orange, M. Ballow, E. R. Stiehm et al., “Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology,” Journal of Allergy and Clinical Immunology, vol. 130, no. 3, supplement, pp. S1–S24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Barton and R. T. Acton, “HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama,” BMC Medical Genetics, vol. 3, article 9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Boucher, M. Mori, E. Milford, and P. G. Beatty, “Estimation of HLA-A, -B, -DR haplotype frequencies in five racial groups represented in the NMDP donor file,” in HLA 1998, D. W. Gjertson and P. I. Terasaki, Eds., pp. 57–78, American Society for Histocompatibility and Immunogenetics, Lenexa, Kan, USA, 1998. View at Google Scholar
  18. E. R. Stiehm, T. W. Chin, A. Haas, and A. G. Peerless, “Infectious complications of the primary immunodeficiencies,” Clinical Immunology and Immunopathology, vol. 40, no. 1, pp. 69–86, 1986. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Hermaszewski and A. D. B. Webster, “Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications,” Quarterly Journal of Medicine, vol. 86, no. 1, pp. 31–42, 1993. View at Google Scholar · View at Scopus
  20. H. Käyhty and J. Eskola, “New vaccines for the prevention of pneumococcal infections,” Emerging Infectious Diseases, vol. 2, no. 4, pp. 289–298, 1996. View at Google Scholar
  21. C. Cunningham-Rundles and C. Bodian, “Common variable immunodeficiency: clinical and immunological features of 248 patients,” Clinical Immunology, vol. 92, no. 1, pp. 34–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Lindberg, “Polyosides (encapsulated bacteria),” Comptes Rendus de l'Académie des Sciences Series III, vol. 322, no. 11, pp. 925–932, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. G. R. Siber, C. Thompson, G. R. Reid et al., “Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease,” The Journal of Infectious Diseases, vol. 165, supplement 1, pp. S129–S133, 1992. View at Google Scholar
  24. D. A. Watson, D. M. Musher, and J. Verhoef, “Pneumococcal virulence factors and host immune responses to them,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 14, no. 6, pp. 479–490, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Schneerson, L. P. Rodrigues, J. C. Parke Jr., and J. B. Robbins, “Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of “natural,” infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.,” The Journal of Immunology, vol. 107, no. 4, pp. 1081–1089, 1971. View at Google Scholar · View at Scopus
  26. P. Anderson, R. B. Johnston Jr., and D. H. Smith, “Human serum activities against Hemophilus influenzae, type b,” Journal of Clinical Investigation, vol. 51, no. 1, pp. 31–38, 1972. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Robbins, J. C. Parke Jr., R. Schneerson, and J. K. Whisnant, “Quantitative measurement of ‘natural’ and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies,” Pediatric Research, vol. 7, no. 3, pp. 103–110, 1973. View at Publisher · View at Google Scholar
  28. M. G. Mikolajczyk, N. F. Concepcion, T. Wang et al., “Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 6, pp. 1158–1164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Roberton, J. Björkander, J. Henrichsen, T. Soderström, and L. A. Hanson, “Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency,” Clinical and Experimental Immunology, vol. 75, no. 2, pp. 201–205, 1989. View at Google Scholar · View at Scopus
  30. L. Hammarström, A. O. Carbonara, M. DeMarchi et al., “Subclass restriction pattern of antigen-specific antibodies in donors with defective expression of IgG or IgA subclass heavy chain constant region genes,” Clinical Immunology and Immunopathology, vol. 45, no. 3, pp. 461–470, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Hammarström, A. O. Carbonara, M. DeMarchi, G. Lefranc, M. P. Lefranc, and C. I. Smith, “Generation of the antibody repertoire in individuals with multiple immunoglobulin heavy chain constant region gene deletions,” Scandinavian Journal of Immunology, vol. 25, no. 2, pp. 189–194, 1987. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Amir, M. G. Scott, M. H. Nahm, and D. M. Granoff, “Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b,” The Journal of Infectious Diseases, vol. 162, no. 1, pp. 163–171, 1990. View at Publisher · View at Google Scholar
  33. D. M. Granoff, G. A. Weinberg, and P. G. Shackelford, “IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine,” Pediatric Research, vol. 24, no. 2, pp. 180–185, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. P. G. Shackelford, “IgG subclasses: importance in pediatric practice,” Pediatrics in Review, vol. 14, no. 8, pp. 291–296, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. E. S. Go and Z. K. Ballas, “Anti-pneumococcal antibody response in normal subjects: a meta-analysis,” Journal of Allergy and Clinical Immunology, vol. 98, no. 1, pp. 205–215, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Bird, J. Lowe, R. P. Stokes, A. G. Bird, N. R. Ling, and R. Jefferis, “The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity,” Journal of Immunological Methods, vol. 71, no. 1, pp. 97–105, 1984. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Kojima, A. Ishizaka, E. Oshika et al., “Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using Pneumovax®-specific antibodies as a reference,” The Tohoku Journal of Experimental Medicine, vol. 161, no. 3, pp. 209–215, 1990. View at Publisher · View at Google Scholar · View at Scopus
  38. D. T. Umetsu, D. M. Ambrosino, and R. S. Geha, “Children with selective IgG subclass deficiency and recurrent sinopulmonary infection: impaired response to bacterial capsular polysaccharide antigens,” Monographs in Allergy, vol. 20, pp. 57–61, 1986. View at Google Scholar · View at Scopus
  39. F. Abrahamian, S. Agrawal, and S. Gupta, “Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy,” Clinical & Experimental Immunology, vol. 159, no. 3, pp. 344–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. C. Barton, L. F. Bertoli, and J. C. Barton, “Comparisons of CVID and IgGSD: referring physicians, autoimmune conditions, pneumovax reactivity, immunoglobulin levels, blood lymphocyte subsets, and HLA-A and -B typing in 432 adult index patients,” Journal of Immunology Research, vol. 2014, Article ID 542706, 10 pages, 2014. View at Publisher · View at Google Scholar
  41. J. C. Barton, L. F. Bertoli, J. C. Barton, and R. T. Acton, “Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections,” Cellular Immunology, vol. 299, pp. 50–57, 2016. View at Publisher · View at Google Scholar
  42. G. S. Cooper, M. L. K. Bynum, and E. C. Somers, “Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases,” Journal of Autoimmunity, vol. 33, no. 3-4, pp. 197–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kraft, G. H. Cassell, J. E. Henson et al., “Detection of Mycoplasma pneumoniae in the airway of adults with chronic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 3, pp. 998–1001, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. R. J. Martin, M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell, “A link between chronic asthma and chronic infection,” Journal of Allergy and Clinical Immunology, vol. 107, no. 4, pp. 595–601, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Mao and E. Cui, “Distribution of pathogens causing nosocomial infection in patients with bronchial asthma,” Genetics and Molecular Research, vol. 14, no. 4, pp. 16146–16150, 2015. View at Publisher · View at Google Scholar
  46. M. Iikura, M. Hojo, R. Koketsu et al., “The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice,” PLoS ONE, vol. 10, no. 4, Article ID e0123584, 2015. View at Publisher · View at Google Scholar
  47. O.-P. Alho, R. Karttunen, and T. J. Karttunen, “Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis,” Clinical & Experimental Immunology, vol. 137, no. 2, pp. 366–372, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. J. C. Barton, C. Leiendecker-Foster, D. M. Reboussin, P. C. Adams, R. T. Acton, and J. H. Eckfeldt, “Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS Study,” Thyroid, vol. 18, no. 8, pp. 831–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. J. G. Hollowell, N. W. Staehling, W. D. Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III),” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Wakiguchi, M. Fujieda, H. Hisakawa, H. Kubota, K. Matsumoto, and T. Kurashige, “Effects of immunosuppressive chemotherapy on serum levels of IgG subclasses—analysis in children with acute lymphoblastic leukemia and in children with aplastic anemia and autoimmune diseases receiving corticosteroid hormone,” Rinsho Ketsueki, vol. 31, no. 12, pp. 1920–1923, 1990. View at Google Scholar · View at Scopus
  51. R. McMillan, R. Longmire, and R. Yelenosky, “The effect of corticosteroids on human IgG synthesis,” The Journal of Immunology, vol. 116, no. 6, pp. 1592–1595, 1976. View at Google Scholar · View at Scopus
  52. O. M. Wolkowitz, N. M. Papadopoulos, R. Costello et al., “Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans,” Psychoneuroendocrinology, vol. 15, no. 2, pp. 155–158, 1990. View at Publisher · View at Google Scholar · View at Scopus
  53. G. A. Settipane, R. K. Pudupakkam, and J. H. McGowan, “Corticosteroid effect on immunoglobulins,” The Journal of Allergy and Clinical Immunology, vol. 62, no. 3, pp. 162–166, 1978. View at Publisher · View at Google Scholar · View at Scopus
  54. N. E. Bianco, R. S. Panush, J. S. Stillman, and P. H. Schur, “Immunologic studies of juvenile rheumatoid arthritis,” Arthritis & Rheumatism, vol. 14, no. 6, pp. 685–696, 1971. View at Publisher · View at Google Scholar · View at Scopus
  55. F. A. Wollheim and R. C. Williams Jr., “Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis,” The New England Journal of Medicine, vol. 274, no. 2, pp. 61–67, 1966. View at Publisher · View at Google Scholar · View at Scopus
  56. A. C. Steere, R. T. Schoen, and E. Taylor, “The clinical evolution of Lyme arthritis,” Annals of Internal Medicine, vol. 107, no. 5, pp. 725–731, 1987. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Yokoyama, H. Kida, Y. Tani et al., “Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels,” Clinical & Experimental Immunology, vol. 61, no. 3, pp. 601–607, 1985. View at Google Scholar · View at Scopus
  58. T. Feizi, “Immunoglobulins in chronic liver disease,” Gut, vol. 9, no. 2, pp. 193–198, 1968. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Levy, T. Espanol-Boren, C. Thomas et al., “Clinical spectrum of X-linked hyper-IgM syndrome,” Journal of Pediatrics, vol. 131, no. 1, part 1, pp. 47–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Revy, T. Muto, Y. Levy et al., “Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2),” Cell, vol. 102, no. 5, pp. 565–575, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Ferrari, S. Giliani, A. Insalaco et al., “Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12614–12619, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Imai, N. Catalan, A. Plebani et al., “Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination,” Journal of Clinical Investigation, vol. 112, no. 1, pp. 136–142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Imai, G. Slupphaug, W.-I. Lee et al., “Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination,” Nature Immunology, vol. 4, no. 10, pp. 1023–1028, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. G. de Lange, Z. Fa-Ming, J. Henke et al., “Immunoglobulin allotypes in a Chinese population: comparison of haplotype frequencies with other Asian groups,” International Journal of Immunogenetics, vol. 12, no. 4-5, pp. 191–195, 1985. View at Publisher · View at Google Scholar
  65. G. G. de Lange, “Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes,” Experimental and Clinical Immunogenetics, vol. 6, no. 1, pp. 7–17, 1989. View at Google Scholar · View at Scopus
  66. C. E. Cook and A. G. Steinberg, “An amino acid substitution in the γ1 chain of human immunoglobulin G associated with the Gm(2) allotype,” Molecular Immunology, vol. 16, no. 8, pp. 555–558, 1979. View at Publisher · View at Google Scholar · View at Scopus
  67. A. M. Goetze, Z. Zhang, L. Liu, F. W. Jacobsen, and G. C. Flynn, “Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood,” Molecular Immunology, vol. 49, no. 1-2, pp. 338–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Morell, F. Skvaril, A. G. Steinberg, E. van Loghem, and W. D. Terry, “Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera,” The Journal of Immunology, vol. 108, no. 1, pp. 195–206, 1972. View at Google Scholar · View at Scopus
  69. I. J. T. Seppälä, H. Sarvas, and O. Mäkelä, “Low concentrations of Gm allotypic subsets G3 mg and G1 mf in homozygotes and heterozygotes,” The Journal of Immunology, vol. 151, no. 5, pp. 2529–2537, 1993. View at Google Scholar · View at Scopus
  70. V.-A. Oxelius, L. Bråbäck, S. Ahlstedt, and B. Björkstén, “Immunoglobulin constant heavy G chain genes as risk factors in childhood allergies,” Clinical and Experimental Allergy, vol. 36, no. 12, pp. 1616–1624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. H. W. Schroeder Jr., Z.-B. Zhu, R. E. March et al., “Susceptibility locus for IgA deficiency and common variable immuno-deficiency in the HLA-DR3, -B8, -A1 haplotypes,” Molecular Medicine, vol. 4, no. 2, pp. 72–86, 1998. View at Google Scholar · View at Scopus
  72. J. C. Barton, L. F. Bertoli, and R. T. Acton, “Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y,” Blood Cells, Molecules, and Diseases, vol. 31, no. 1, pp. 102–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Beasley, U. Keil, E. Von Mutius, and N. Pearce, “Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC,” The Lancet, vol. 351, no. 9111, pp. 1225–1232, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. C. G. Mortz, J. M. Lauritsen, C. Bindslev-Jensen, and K. E. Andersen, “Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis,” British Journal of Dermatology, vol. 144, no. 3, pp. 523–532, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. C. C. Murphy, R. T. Acton, B. O. Barger et al., “Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies,” Clinical Genetics, vol. 23, no. 6, pp. 405–414, 1983. View at Google Scholar · View at Scopus
  76. R. T. Acton, L. Harman, R. C. P. Go, M.-L. Tseng, and W. Bias, “Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina,” Transplantation Proceedings, vol. 25, no. 4, pp. 2404–2407, 1993. View at Google Scholar · View at Scopus